Lifecore Biomedical, Inc. (LFCR) Earning

$6.87

south_east
-$0.75 (-9.84%)
Day's range
$6.72
Day's range
$7.59

Lifecore Biomedical, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 1 -$0.15 -$0.15 -$0.15
Q2 2025 1 -$0.04 -$0.04 -$0.04
Q3 2025 1 -$0.33 -$0.33 -$0.33
Q4 2025 1 -$0.18 -$0.18 -$0.18
Q1 2026 1 -$0.12 -$0.12 -$0.12
Q2 2026 1 -$0.03 -$0.03 -$0.03
Q3 2026 1 -$0.33 -$0.33 -$0.33
Q4 2026 1 -$0.22 -$0.22 -$0.22
Q1 2027 1 -$0.15 -$0.15 -$0.15
Q2 2027 1 -$0.07 -$0.07 -$0.07

Lifecore Biomedical, Inc. Earnings Date And Information

Lifecore Biomedical, Inc. last posted its earnings results on Thursday, January 2nd, 2025. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.02. The company had revenue of 32.56 M for the quarter and had revenue of 128.26 M for the year. Lifecore Biomedical, Inc. has generated $0 earnings per share over the last year ($0.33 diluted earnings per share) and currently has a price-to-earnings ratio of -15.5. Lifecore Biomedical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based on prior year's report dates.

Lifecore Biomedical, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
01/02/2025 Q2 2025 -$0.27 -$0.25 0.02 $29.75 M $32.56 M
10/04/2024 Q1 2025 N/A -$0.53 N/A N/A $24.71 M
08/26/2024 Q4 2024 -$0.12 -$0.23 -0.11 N/A $37.89 M
08/09/2024 Q3 2024 -$0.12 $0.51 0.63 N/A $35.70 M
08/09/2024 Q2 2024 -$0.12 $0.47 0.59 N/A $30.15 M
08/09/2024 Q1 2024 -$0.12 -$0.35 -0.23 N/A $24.52 M
03/19/2024 Q4 2023 N/A -$1.19 N/A N/A $31.55 M
06/02/2023 Q3 2023 N/A -$1.20 N/A N/A $26.54 M
03/16/2023 Q2 2023 -$0.04 -$0.42 -0.38 N/A $21.86 M
03/16/2023 Q1 2023 -$0.04 -$0.38 -0.34 N/A $43.36 M
03/16/2023 Q4 2022 -$0.04 -$1.24 -1.2 N/A $47.63 M
02/27/2022 Q3 2022 N/A -$0.45 N/A N/A $53.07 M
11/30/2021 Q2 2022 N/A -$1.30 N/A N/A $129.49 M
08/31/2021 Q1 2022 N/A -$0.32 N/A N/A $128.79 M
05/31/2021 Q4 2021 N/A -$0.10 N/A N/A $139.83 M
02/27/2021 Q3 2021 N/A -$0.19 N/A N/A $137.78 M
11/30/2020 Q2 2021 N/A -$0.47 N/A N/A $130.90 M
08/31/2020 Q1 2021 N/A -$0.38 N/A N/A $135.64 M
05/31/2020 Q4 2020 N/A -$0.52 N/A N/A $156.13 M
02/28/2020 Q3 2020 N/A -$0.39 N/A N/A $152.93 M

Lifecore Biomedical, Inc. Earnings: FAQ's

Lifecore Biomedical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based offlast year's report dates.

In the previous quarter, Lifecore Biomedical, Inc. (:LFCR) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.02.

The conference call for Lifecore Biomedical, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Lifecore Biomedical, Inc.'s latest earnings report can be read online.

Lifecore Biomedical, Inc. (:LFCR) has a recorded annual revenue of $128.26 M.

Lifecore Biomedical, Inc. (:LFCR) has a recorded net income of $12.01 M.Lifecore Biomedical, Inc. has generated $0.39 earnings per share over the last four quarters.

Lifecore Biomedical, Inc. (:LFCR) has a price-to-earnings ratio of -15.5 and price/earnings-to-growth ratio is 0.05.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED